Impax Laboratories
Hayward
About Impax Laboratories
Impax Laboratories, Inc. is a technology-based, specialty pharmaceutical company. The Company is focused on the development and commercialization of bioequivalent and brand-name pharmaceuticals. In the generic pharmaceuticals market, the Company focuses on controlled-release generic versions of brand-name pharmaceuticals, covering a range of therapeutic areas. In the brand-name pharmaceuticals market, the Company is developing products for the treatment of central nervous system (CNS) disorders. The Company's brand-name product portfolio consists of development-stage projects to which the Company applies its formulation and development expertise to develop differentiated, modified, or controlled-release versions of marketed drug substances. It operates in two segments: Global Pharmaceuticals Division (Global Division) and the Impax Pharmaceuticals Division (Impax Division).
Company Facts
- Operating status: Closed
- Company type: For Profit
- IPO status: Delisted
- Employees: 1,001 – 5,000
- Ticker: nasdaq:IPXL
- Website: impaxlabs.com
- Phone: 2155584333
Industries & Categories
Biotechnology, Health Diagnostics, Pharmaceutical
Social Profiles
Canonical: https://fsome.com/organization/impax-laboratories-2658513 · For the full interactive profile (charts, investors, team, acquisitions, press), please enable JavaScript.